| __timestamp | Agios Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 179279000 |
| Thursday, January 1, 2015 | 141827000 | 186359000 |
| Friday, January 1, 2016 | 220163000 | 171785000 |
| Sunday, January 1, 2017 | 292681000 | 208136000 |
| Monday, January 1, 2018 | 1397000 | 198405000 |
| Tuesday, January 1, 2019 | 1317000 | 224169000 |
| Wednesday, January 1, 2020 | 2805000 | 245044000 |
| Friday, January 1, 2021 | 18777000 | 252314000 |
| Saturday, January 1, 2022 | 1704000 | 268225000 |
| Sunday, January 1, 2023 | 9504000 | 304629000 |
| Monday, January 1, 2024 | 4165000 | 324203000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial. From 2014 to 2023, Agios Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have shown distinct trajectories in their cost of revenue. Agios Pharmaceuticals experienced a significant peak in 2017, with costs surging by over 100% compared to 2016. However, post-2017, Agios saw a dramatic decline, with costs dropping by nearly 99% in 2018. This volatility highlights the challenges faced by emerging biotech firms.
Conversely, Taro Pharmaceuticals demonstrated a more stable and upward trend. From 2014 to 2023, Taro's cost of revenue increased by approximately 70%, reflecting consistent growth and operational efficiency. Notably, 2023 marked a record high for Taro, with costs reaching their peak. This comparison underscores the diverse financial strategies and market positions of these two companies, offering valuable insights for investors and industry analysts.
Cost of Revenue: Key Insights for Novo Nordisk A/S and Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: AstraZeneca PLC vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Pfizer Inc. and Taro Pharmaceutical Industries Ltd.'s Expenses
Cost Insights: Breaking Down Viatris Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue Comparison: Insmed Incorporated vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Catalent, Inc. vs Agios Pharmaceuticals, Inc.
Xenon Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.
Cost Insights: Breaking Down Supernus Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Evotec SE
Cost Insights: Breaking Down Taro Pharmaceutical Industries Ltd. and Dyne Therapeutics, Inc.'s Expenses
Cost of Revenue Trends: Taro Pharmaceutical Industries Ltd. vs Celldex Therapeutics, Inc.